Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

MorphoSys and Pharmacia & Upjohn suspend joint research program

Aug. 20, 1998

No Comments

Genzyme division and Bayer enter into genomics agreement

Aug. 20, 1998

No Comments

Genome Therapeutics and Cadus join forces in the search for new therapeutic targets

Aug. 19, 1998

No Comments

Matrix granted Japanese patent; U.S. patent reissued

Aug. 18, 1998

No Comments

MorphoSys and DuPont Pharmaceuticals sign collaboration agreement

Aug. 14, 1998

No Comments

Fusion protein enables large-scale production of bioactive carbohydrates

Aug. 14, 1998

No Comments

Idun to license patent application for apoptosis model

Aug. 13, 1998

No Comments

Gene screening technology developed at Harvard Medical School licensed to Versicor

Aug. 10, 1998

No Comments

Label expansion for CEPRATE SC approved

July 31, 1998

No Comments

Alizyme granted exclusive worldwide license to BTG drug delivery technology

July 31, 1998

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Drug design, drug delivery and technologies
RSS

MorphoSys and Pharmacia & Upjohn suspend joint research program

Genzyme division and Bayer enter into genomics agreement

Genome Therapeutics and Cadus join forces in the search for new therapeutic targets

Matrix granted Japanese patent; U.S. patent reissued

MorphoSys and DuPont Pharmaceuticals sign collaboration agreement

Fusion protein enables large-scale production of bioactive carbohydrates

Idun to license patent application for apoptosis model

Gene screening technology developed at Harvard Medical School licensed to Versicor

Label expansion for CEPRATE SC approved

Alizyme granted exclusive worldwide license to BTG drug delivery technology

Today's news in brief

Today's news in brief

Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal

Proteomics study explores how protein changes influence disease

Abbvie and Simcere enter a $1B T-cell engager deal

Drug design, drug delivery and technologies RSS

Drug design, drug delivery and technologies
RSS